Literature DB >> 301527

Autoantibodies to B lymphocytes in a patient with hypoimmunoglobulinemia. Characterization and pathogenic role.

T Tursz, J L Preud'homme, S Labaume, C Matuchansky, M Seligmann.   

Abstract

In a young woman with ulcerative colitis, hypoimmunoglobulinemia, and humoral immunodeficiency, lymphocyte counts vary between 600 and 1,000 per mm(3) with 0.5-1.5% bone marrow-derived (B) cells and 98-99% thymus-derived (T) cells. Anti-lymphocyte antibodies were detected by immunofluorescence and by microlymphocytotoxicity with increased reactivity at +4 degrees C. They belonged to the IgM class and were polyclonal. Studies performed with various normal lymphocyte subpopulations, several lymphoblastoid cell lines and lymphocytes from immunodeficiency patients showed that these antibodies reacted with B cells. The corresponding antigen(s) is distinct from membrane-bound immunoglobulins, is not an alloantigen, and is probably unrelated to the la-like molecules. Pokeweed mitogen stimulated B cells appear to lose this antigen. Cells from various lymphoproliferative disorders were tested. T-derived and "non T-non-B" leukemic cells did not react with the antibody. Malignant cells from B-derived lymphomas and prolymphocytic leukemias were reactive. The incidence of positivity of the leukemic cells among patients with common B chronic lymphocytic leukemia was surprisingly low (one-third of the patients). The autoantibody nature of the anti-B-cell antibodies and their pathogenic role in the genesis of the patient's hypoimmunoglobulinemia was demonstrated by the effect of removal of antibodies by massive plasmaphereses which were followed by a dramatic and transitory increase of B-cell figures. Whereas most primary immunodeficiency syndromes appear to result from an arrest in the differentiation capabilities of immunologically competent cells, autoantibodies to circulating B lymphocytes may be incriminated in the pathogenesis of some cases of hypogammaglobulinemia.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301527      PMCID: PMC372381          DOI: 10.1172/JCI108789

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  10 in total

1.  Prolymphocytic leukaemia.

Authors:  D A Galton; J M Goldman; E Wiltshaw; D Catovsky; K Henry; G J Goldenberg
Journal:  Br J Haematol       Date:  1974-05       Impact factor: 6.998

2.  Recurrent infections, episodic lymphopenia and impaired cellular immunity.

Authors:  R Kretschmer; C S August; F S Rosen; C A Janeway
Journal:  N Engl J Med       Date:  1969-08-07       Impact factor: 91.245

3.  Studies with B-cell allo- and hetero-antisera: parallel reactivity and special properties.

Authors:  R J Winchester; C Y Wang; J Halper; T Hoffman
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

Review 4.  B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins.

Authors:  M Seligmann; J L Preud'Homme; J C Brouet
Journal:  Transplant Rev       Date:  1973

5.  Serum lymphocytotoxins in inflammatory bowel disease. Studies of frequency and specificity for lymphocyte subpopulations.

Authors:  R G Strickland; E M Friedler; C A Henderson; I D Wilson; R D Williams
Journal:  Clin Exp Immunol       Date:  1975-09       Impact factor: 4.330

6.  Distribution of Ia-like molecules on the surface of normal and leukemic human cells.

Authors:  S F Schlossman; L Chess; R E Humphreys; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

7.  Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients.

Authors:  J C Brouet; M Sasportes; G Flandrin; J L Preud'Homme; M Seligmann
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

8.  Analyses of lymphocytes from patients with rheumatoid arthritis and systemic lupus erythematosus. Occurrence of interfering cold-reactive antilymphocyte antibodies.

Authors:  R J Winchester; J B Winfield; F Siegal; P Wernet; Z Bentwich; H G Kunkel
Journal:  J Clin Invest       Date:  1974-11       Impact factor: 14.808

9.  Human B-lymphocyte antigens expressed by lymphocytic and myelocytic leukemia cells. I. Detection by rabbit antisera.

Authors:  R Billing; B Rafizadeh; I Drew; G Hartman; R Gale; P Terasaki
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

10.  Recognition by pregnancy serums of non-HL-A alloantigens selectively expressed on B lymphocytes.

Authors:  R J Winchester; P Wernet; H G Kunkel; B Dupont; C Jersild; S M Fu
Journal:  J Exp Med       Date:  1975-04-01       Impact factor: 14.307

  10 in total
  4 in total

1.  Antihelper T cell autoantibody in acquired agammaglobulinemia.

Authors:  A Rubinstein; M Sicklick; V Mehra; F S Rosen; R H Levey
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

2.  Lymphocyte subpopulations in primary immunodeficiency disorders.

Authors:  S Gupta
Journal:  Indian J Pediatr       Date:  1982 May-Jun       Impact factor: 1.967

3.  Glucocorticosteroid enhancement of immunoglobulin synthesis by pokeweed mitogen-stimulated human lymphocytes. III. Common variable immunodeficiency.

Authors:  D A Cooper; P Hansen; M Duckett; J B Ziegler; R Penny
Journal:  Clin Exp Immunol       Date:  1981-08       Impact factor: 4.330

4.  Autologous mixed lymphocyte reaction in man. IV. Decreased autologous mixed lymphocyte culture response in patients with common variable immunodeficiency.

Authors:  S Gupta; N K Damle
Journal:  J Clin Immunol       Date:  1983-01       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.